MENU
+Compare
IRIX
Stock ticker: NASDAQ
AS OF
Sep 15 closing price
Price
$1.28
Change
-$0.04 (-3.03%)
Capitalization
21.75M

IRIX IRIDEX Corp Forecast, Technical & Fundamental Analysis

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology... Show more

IRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IRIX with price predictions
Sep 12, 2025

IRIX's Stochastic Oscillator dives oversold zone

The Stochastic Oscillator for IRIX moved into oversold territory on September 12, 2025. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IRIX advanced for three days, in of 222 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 115 cases where IRIX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 12, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on IRIX as a result. In of 103 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for IRIX turned negative on September 12, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRIX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IRIX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (370.370) is normal, around the industry mean (60.236). P/E Ratio (0.000) is within average values for comparable stocks, (38.113). IRIX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.622). IRIX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (0.429) is also within normal values, averaging (80.051).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IRIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
IRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IRIX is expected to report earnings to -5 cents per share on November 18

IRIDEX Corp IRIX Stock Earnings Reports
Q3'25
Est.
$-0.06
Q2'25
Beat
by $0.03
Q1'25
Est.
$-0.10
Q4'24
Est.
$-0.05
Q3'24
Missed
by $0.03
The last earnings report on August 12 showed earnings per share of -5 cents, beating the estimate of -9 cents. With 53.71K shares outstanding, the current market capitalization sits at 21.75M.
A.I. Advisor
published General Information

General Information

a manufacturer of light-based medical systems and delivery devices

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1212 Terra Bella Avenue
Phone
+1 650 940-4700
Employees
139
Web
https://www.iridex.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LIQT2.510.24
+10.61%
LiqTech International
AVO12.850.11
+0.86%
Mission Produce
RUSHA55.860.20
+0.36%
Rush Enterprises
BLFY9.20-0.02
-0.22%
Blue Foundry Bancorp
CPRT47.60-0.80
-1.65%
Copart

IRIX and Stocks

Correlation & Price change

A.I.dvisor tells us that IRIX and NTRA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IRIX and NTRA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRIX
1D Price
Change %
IRIX100%
-3.03%
NTRA - IRIX
30%
Poorly correlated
+2.17%
CNTGF - IRIX
28%
Poorly correlated
+18.18%
NEO - IRIX
27%
Poorly correlated
+1.51%
IQV - IRIX
27%
Poorly correlated
-0.67%
MDXH - IRIX
26%
Poorly correlated
-0.81%
More

Groups containing IRIX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRIX
1D Price
Change %
IRIX100%
-3.03%
Medical/Nursing Services
industry (225 stocks)
19%
Poorly correlated
+0.94%
Health Services
industry (437 stocks)
14%
Poorly correlated
+0.31%